Allianz Asset Management’s Health Catalyst HCAT Stock Holding History

Allianz Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,201	Closed	-$523K	–	2501
2021 Q4	$523K	Sell	13,201 -212,772	-94%	-$9.7M	﹤0.01%	2177
2021 Q3	$11.3M	Sell	225,973 -47,426	-17%	-$2.59M	0.01%	971
2021 Q2	$15.2M	Buy	273,399 +38,199	+16%	+$2.03M	0.01%	719
2021 Q1	$11M	Sell	235,200 -20,532	-8%	-$995K	0.01%	805
2020 Q4	$11.1M	Buy	255,732 +45,754	+22%	+$1.69M	0.01%	804
2020 Q3	$7.68M	Sell	209,978 -22,384	-10%	-$760K	0.01%	847
2020 Q2	$6.78M	Buy	232,362 +7,425	+3%	+$205K	0.01%	1062
2020 Q1	$5.88M	Buy	224,937 +71,838	+47%	+$2.19M	0.01%	1085
2019 Q4	$5.31M	Buy	+153,099	New	+$5.07M	﹤0.01%	1459

Other funds holding HCAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Allianz Asset Management's HCAT Position: Q1 2022 in Review

Allianz Asset Management sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 13,201 shares — an estimated $523K sold.

Allianz Asset Management first reported a position in HCAT in Q4 2019 and held it in 9 quarters. The position peaked at $15.2M in Q2 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

Allianz Asset Management reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
Allianz Asset Management sold 13,201 Health Catalyst shares in Q1 2022, an estimated $523K.
Allianz Asset Management first reported a position in Health Catalyst in Q4 2019 and held it in 9 quarters.
Allianz Asset Management's Health Catalyst position peaked at $15.2M in Q2 2021.
185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on Allianz Asset Management's 13F filing for Q1 2022, filed 13 May 2022.